Siamab

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

cCAM Biotherapeutics

The company develops monoclonal antibody immunotherapies to treat cancer patients with advanced or recurrent malignancies.

Epsilogen

This company develops immunoglobulin E and A based antibody therapeutics to treat patients with solid tumours and ovarian cancer.

Arch Oncology

This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.

Abologix

The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.

Akiram Therapeutics

This biotech company develops targeted radiopharmaceuticals and radioimmunotherapies for patients with solid tumours and metastatic cancers.

Signadori Bio

This biopharmaceutical company develops a monocyte-based cell therapy platform to treat patients with solid tumours.